<DOC>
	<DOCNO>NCT01075152</DOCNO>
	<brief_summary>The Cryptococcal Optimal ART Timing ( COAT ) trial seek determine cryptococcal meningitis ( CM ) whether early initiation antiretroviral therapy ( ART ) prior hospital discharge result superior survival compare standard initiation ART start outpatient .</brief_summary>
	<brief_title>Cryptococcal Optimal ART Timing Trial</brief_title>
	<detailed_description>After 7-11 day amphotericin B therapy , subject randomize 1:1 allocation : - Early initiation ART ( Experimental Group ) = ART initiate within 48 hour study entry , OR - Standard initiation ART ( Control Group ) = ART &gt; =4 week study entry HIV therapy efavirenz plus nucleoside backbone per national guideline first line therapy .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Meningitis</mesh_term>
	<mesh_term>Meningitis , Cryptococcal</mesh_term>
	<mesh_term>Efavirenz</mesh_term>
	<mesh_term>Lamivudine</mesh_term>
	<criteria>HIVinfection , document ELISA Antiretroviral medication na√Øve ( exclude mothertochild transmission therapy ) Age &gt; 14 year Cryptococcal meningitis diagnose either culture CSF cryptococcal antigen ( CRAG ) Ability willingness participant legal guardian/representative give inform consent . Receiving amphotericinbased antifungal therapy Study entry prior receipt &lt; 7 day &gt; 11 day amphotericin therapy History prior , know cryptococcal meningitis Inability take enteral medication Receiving chemotherapy immunosuppressant medication Can unlikely attend regular clinic visit Contraindication immediate delay HIV therapy base serious comorbidities coinfections , laboratory value Pregnancy Breastfeeding Female participant childbearing potential participate sexual activity could lead pregnancy must agree use two reliable method contraception</criteria>
	<gender>All</gender>
	<minimum_age>14 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2015</verification_date>
	<keyword>cryptococcal meningitis</keyword>
	<keyword>cryptococcus</keyword>
	<keyword>cryptococcosis</keyword>
	<keyword>HIV</keyword>
	<keyword>AIDS</keyword>
	<keyword>strategy</keyword>
</DOC>